Chronic systemic inflammation in IBD plays a crucial role in atherosclerosis progression, contributing to CVD risk by promoting endothelial dysfunction, oxidative stress, and macrophage accumulation through elevated markers such as CRP [9,23]. This evidence concerns the gene CRP and endothelial dysfunction.